Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 11.12.2025 QSEP.LN IE000FQ808R5 650,002.00 USD 14,885,145.46 22.900  ...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc Series 2025-2 Class E REG S XS3096176063 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571374% Margin: 3% Total Rate: 6.97571374% Number of Days: 28 Day Count: Actual / 365 (Fixed) Interest Frequency...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 11.12.2025 IPXE.IM IE00BFD26097   75,002.00 EUR   1,707,802.96   22.770  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 11.12.2025 GMAY.LN IE000P0FL8E3 1,000,002.00 USD 38,197,855.90 38.198  ...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc Series 2025-2 Class E 144A XS3096176147 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571% Margin: 3% Total Rate: 6.97571% Number of Days: 28 Day Count: Actual / 365 (Fixed) Interest Frequency: Month...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc Series 2025-2 Class D REG S XS3096175412 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571% Margin: 1.75% Total Rate: 5.72571% Number of Days: 28 Day Count: Actual / 365 (Fixed) Interest Frequency: M...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc Series 2025-2 Class D 144A XS3096175685 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571% Margin: 1.75% Total Rate: 5.72571% Number of Days: 28 Day Count: Actual / 365 (Fixed) Interest Frequency: Mo...
-

HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  10-December-2025 Issue: Newday Funding Master Issuer Plc Series 2025-2 Class C 144A XS3096175172 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 17-November-2025 Date To: 15-December-2025 Record Date: 12-December-2025 Value Date: 15-December-2025 Benchmark Rate: 3.97571374% Margin: 1.5% Total Rate: 5.47571374% Number of Days: 28 Day Count: Actual / 365 (Fixed) Interest Frequenc...
-

ImmunityBio Receives Conditional Marketing Authorization Recommendation from the European Medicines Agency for ANKTIVA® with BCG for Non-Muscle Invasive Bladder Cancer Carcinoma in Situ—A First in Europe

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio (NASDAQ: IBRX), a leading immunotherapy company, announced today that the European Medicines Agency has recommended granting a conditional marketing authorization in the EU for ANKTIVA® (nogapendekin alfa inbakicept) in combination with Bacillus Calmette-Guérin (BCG) for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ. This recommendation will help facilitate early access to medicines that address c...
-

Shoe Carnival Declares Quarterly Cash Dividend and Announces New $50 Million Share Repurchase Program

FORT MILL, S.C.--(BUSINESS WIRE)--Shoe Carnival, Inc. (Nasdaq: SCVL) (the “Company”), a leading retailer of footwear and accessories for the family, announced today that its Board of Directors approved the payment of a quarterly cash dividend of $0.15 per share to be paid on January 26, 2026, to shareholders of record as of the close of business on January 12, 2026. Additionally, its Board of Directors authorized a new share repurchase program for up to $50 million of its outstanding common sto...